Memantine for behavioral disturbances in frontotemporal dementia: a case series
- PMID: 17545743
- DOI: 10.1097/WAD.0b013e318047df5d
Memantine for behavioral disturbances in frontotemporal dementia: a case series
Abstract
Background: Frontotemporal dementia (FTD) is one of the more common presenile dementias. Unlike Alzheimer disease, there are no approved medications to treat this debilitating condition.
Objective: To report the response of memantine on the behavioral manifestations of FTD.
Design: Case series of 3 patients diagnosed with FTD and treated with memantine.
Results: All 3 patients showed an improvement in total Neuropsychiatric Inventory score with specific improvements in the subscale scores of apathy, agitation, and anxiety. Memantine was well tolerated in all patients.
Conclusions: This small case series supports the notion that memantine may have a beneficial effect on the neuropsychiatric symptoms of FTD and should be further studied in a prospective clinical trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
